QD 112
Alternative Names: QD-112Latest Information Update: 01 Oct 2021
At a glance
- Originator Zhuhai Qiwei Biotechnology
- Class Eye disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Dry eyes
Most Recent Events
- 30 Sep 2021 Early research in Dry eyes in China (Ophthalmic) (Zhuhai Qiwei Biotechnology pipeline, September 2021)